LICART

Peak

diclofenac epolamine

NDATOPICALSYSTEM
Approved
Dec 2018
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1

Mechanism of Action

analgesic, anti-inflammatory, and antipyretic properties. The mechanism of action of diclofenac, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2). Diclofenac is a potent inhibitor of prostaglandin synthesis in vitro. Diclofenac…

Clinical Trials (1)

NCT05171673Phase 3Completed

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants with Minor Soft Tissue Injury

Started Oct 2021

Loss of Exclusivity

LOE Date
Feb 20, 2035
109 months away
Patent Expiry
Feb 20, 2035

Patent Records (2)

Patent #ExpiryTypeUse Code
11344520
Feb 20, 2035
U-3393
11351133
Feb 20, 2035
U-3393